Biotech Advances This Week 1. Merck acquires Cidara Therapeutics What happened:  Merck announced a $9.2B acquisition  of Cidara Therapeutics. Why it matters: Cidara’s long-acting influenza antiviral  becomes a major strategic asset for Merck. Could shift flu treatment toward long-protection antivirals  rather than single-episode therapy. Impact:  Strengthens preparedness for seasonal and pandemic influenza and signals strong investment in next-generation antivirals. 2. FDA pr

Commodity Table Commodity   Category Latest Price (₹) 1-Week Trend Market Note Wheat Food Grain ₹2,520/quintal Up Slight supply tightness and rising demand. Rice (Non-Basmati) Food Grain   ₹3,100/quintal Down Stable supply, mild correction. Sugar Soft Commodity ₹3,650/quintal Up Higher festive demand supporting prices. Soybean Oilseed     ₹4,850/quintal Down Increased arrivals in mandis. Palm Oil Edible Oil   ₹92/kg Up Imported prices increased globally. Crude Oil (Brent)   E

Latest Worldwide Advances in Disease Care Services, Second Week of November 2025   Introduction The global landscape of disease care services during the week of November 6-14, 2025, is defined by a critical inflection point where governance is accelerating to manage profound technological advancement and the financial pressures it creates. This report provides an expert-level analysis of worldwide developments, focusing on infectious diseases, diabetes, and neurological disor